Upadacitinib Recommended for Nonradiographic AxSpA in Europe Upadacitinib Recommended for Nonradiographic AxSpA in Europe

The Janus kinase inhibitor is already approved for the treatment of active ankylosing spondylitis in the European Union.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Alert Source Type: news